Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer

Anna Isinger Ekstrand

Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer

Anna Isinger Ekstrand

Institutionen för immunteknologi

Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

1 Nedladdningar (Pure)

Sammanfattning

Popular Abstract in Swedish
Varje år drabbas i världen ca 3 miljoner individer av cancer i mag-tarmkanalen. Stora skillnader finns i incidens med magsäckscancer och matstrupscancer särskilt vanliga i utvecklingsländer, medan tjock- och ändtarmscancer är en av de vanligaste tumörtyperna i västvärlden. Cancer i mag-tarmkanalen ger ofta diffusa symtom, vilket i många fall leder till att tumörerna upptäcks i sena stadier. Idag är 5-årsöverlevnaden 10-20% vid cancer i matstrupe och magsäck och 50% i tjock- och ändtarm. Cancer i mag-tarmkanalen är generellt genetiskt komplex med en rad förvärvade genetiska avvikelser. Kartläggning av dessa genetiska avvikelser och de förändringar i cellens signalvägar de leder till är av betydelse såväl för diagnostik som för att förutse patientens risk för återfall (prognostik) och för att välja bästa behandling (prediktion). Avhandlingen kan indelas i två delar; en som omfattar genetiska profiler i matstrupscancer och en som undersökt mutationer och påverkan på signalkedjor i ärftlig tjock- och ändtarmscancer. I studie I kartlades över- och underskott av genetiskt material i skivepitelcancer i matstrupen. Genetiska avvikelser på kromosomerna 1p36 och 19p13 kunde kopplas till prognos. I studie II undersöktes cancrar som uppkommit på olika platser i matstrupen och magsäcken med kartläggning av mängden genetiskt material och uttrycket av alla arvsmassans gener. Cancer i matstrupen och i övergången till magsäcken visade sig genetiskt lika, medan tumörer i magsäcken uppvisade delvis andra genetiska mönster. Studierna III-V handlar om ärftlig tjock- och ändtarmscancer. I studie III fastställdes att bärarskap av 1100delC mutationen i låg-risk genen CHEK2 var relativt ovanligt (2.5%) hos kvinnor som utvecklat både bröstcancer och tjock- och ändtarmscancer. I studierna IV och V undersöktes tarmscancrar från individer med det ärftliga syndromet hereditär nonpolypos kolorektalcancer (HNPCC). Förändringar i form av mutationer och ändrat uttryck i två olika signalvägar påvisades i en stor del av cancrarna.

Originalspråk	engelska
Kvalifikation	Doktor
Tilldelande institution	Bröstcancer-genetik
Handledare	Nilbert, Mef, handledare Borg, Åke, handledare Johansson, Maria C, handledare
Tilldelningsdatum	2010 maj 6
Förlag	Lund University: Faculty of Medicine
ISBN (tryckt)	978-91-86443-61-0
Status	Published - 2010

Bibliografisk information

Defence details

Date: 2010-05-06
Time: 09:00
Place: Segerfalk lecture hall, Lund

External reviewer(s)

Name: Melin, Beatrice
Title: Associate professor
Affiliation: Department of Radiation Sciences, Umeå University, Umeå

---

Ämnesklassifikation (UKÄ)

Cancer och onkologi

Andra filer och länkar

Isinger Ekstrand, A.: Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer
Maria C Johansson (Andra handledare)
2010 → …
Aktivitet: Examination och handledarskap › Handledning av forskarstuderande

Citera det här

@phdthesis{59c92caf00554747b7febf7e153c6919,

title = "Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer",

abstract = "Esophageal cancer and colorectal cancer represents two major types of gastrointestinal tumors. Though refined surgery and introduction of novel chemotherapeutics have improved outcome, more than 2500 Swedes die from these diseases every year. Novel markers for early diagnosis, prognosis and treatment prediction are therefore needed. This thesis aimed to genetically profile esophageal cancer with correlations to tumor location and prognosis, to explore the contribution of a low-risk allele, and to characterize involvement of signaling pathways in hereditary colorectal cancer. In paper I, 32k array comparative genomic hybridization (aCGH) was used to genomically profile esophageal squamous cell cancer with correlations to prognosis. Copy number alterations affected median 19% of the genome and included frequent alterations of EGFR and CDKN2A. Gain of 7p22.3 predicted nodal metastasis and gain of 1p36.32 and 19p13.3 predicted poor survival. In paper II, aCGH and gene expression profiling were used to identify genetic differences between adenocarcinomas arising at different locations – in the distal esophagus, the gastroesophageal junction and the proximal stomach. Within these genetically complex tumors, extensive similarities were detected in gains/losses and well as gene expression patterns between adenocarcinomas in the distal esophagus and the gastroesophageal junction, whereas gastric cancers showed different profiles. Upregulation of CDK6 and EGFR were found in approximately one quarter of the tumors, which provides molecular support for exploration of these markers as therapeutic targets in gastroesophageal adenocarcinoma. In paper III, the low-risk CHEK2 1100delC allele was characterized in women with metachronous breast cancer and colorectal cancer. The 1100delC allele was identified in 2.5% of the women, compared to 1% in the population. Though alterations in low/moderate risk alleles are increasingly recognized to contribute to hereditary cancer, these findings exclude this CHEK2 variant as a major cause of metachronous breast and colorectal cancer in Swedish women. In papers IV and V, alterations in the PI3K/AKT/mTOR and Wnt signaling pathways were studied in colorectal cancers linked to the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Frequent alterations in these pathways were demonstrated and included mutations of PIK3CA and KRAS and altered immunohistochemical expression of PIK3CA, p-AKT, PTEN, TCF4, {\ss}-catenin and E-cadherin. Therapeutic strategies directed at these pathways are thus likely relevant also in HNPCC-associated cancers.",

keywords = "Esophageal cancer, hereditary cancer, HNPCC, copy number analysis, CGH, gene expression, Wnt, PIK3CA, CHEK2, gastric cancer, colorectal cancer",

author = "{Isinger Ekstrand}, Anna",

note = "Defence details Date: 2010-05-06 Time: 09:00 Place: Segerfalk lecture hall, Lund External reviewer(s) Name: Melin, Beatrice Title: Associate professor Affiliation: Department of Radiation Sciences, Ume{\aa} University, Ume{\aa} ---",

year = "2010",

language = "English",

isbn = "978-91-86443-61-0",

series = "Lund University Faculty of Medicine Doctoral Dissertation Series ",

publisher = "Lund University: Faculty of Medicine",

school = "Breastcancer-genetics",

}

TY - THES

T1 - Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer

AU - Isinger Ekstrand, Anna

N1 - Defence details Date: 2010-05-06 Time: 09:00 Place: Segerfalk lecture hall, Lund External reviewer(s) Name: Melin, Beatrice Title: Associate professor Affiliation: Department of Radiation Sciences, Umeå University, Umeå ---

PY - 2010

Y1 - 2010

N2 - Esophageal cancer and colorectal cancer represents two major types of gastrointestinal tumors. Though refined surgery and introduction of novel chemotherapeutics have improved outcome, more than 2500 Swedes die from these diseases every year. Novel markers for early diagnosis, prognosis and treatment prediction are therefore needed. This thesis aimed to genetically profile esophageal cancer with correlations to tumor location and prognosis, to explore the contribution of a low-risk allele, and to characterize involvement of signaling pathways in hereditary colorectal cancer. In paper I, 32k array comparative genomic hybridization (aCGH) was used to genomically profile esophageal squamous cell cancer with correlations to prognosis. Copy number alterations affected median 19% of the genome and included frequent alterations of EGFR and CDKN2A. Gain of 7p22.3 predicted nodal metastasis and gain of 1p36.32 and 19p13.3 predicted poor survival. In paper II, aCGH and gene expression profiling were used to identify genetic differences between adenocarcinomas arising at different locations – in the distal esophagus, the gastroesophageal junction and the proximal stomach. Within these genetically complex tumors, extensive similarities were detected in gains/losses and well as gene expression patterns between adenocarcinomas in the distal esophagus and the gastroesophageal junction, whereas gastric cancers showed different profiles. Upregulation of CDK6 and EGFR were found in approximately one quarter of the tumors, which provides molecular support for exploration of these markers as therapeutic targets in gastroesophageal adenocarcinoma. In paper III, the low-risk CHEK2 1100delC allele was characterized in women with metachronous breast cancer and colorectal cancer. The 1100delC allele was identified in 2.5% of the women, compared to 1% in the population. Though alterations in low/moderate risk alleles are increasingly recognized to contribute to hereditary cancer, these findings exclude this CHEK2 variant as a major cause of metachronous breast and colorectal cancer in Swedish women. In papers IV and V, alterations in the PI3K/AKT/mTOR and Wnt signaling pathways were studied in colorectal cancers linked to the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Frequent alterations in these pathways were demonstrated and included mutations of PIK3CA and KRAS and altered immunohistochemical expression of PIK3CA, p-AKT, PTEN, TCF4, ß-catenin and E-cadherin. Therapeutic strategies directed at these pathways are thus likely relevant also in HNPCC-associated cancers.

AB - Esophageal cancer and colorectal cancer represents two major types of gastrointestinal tumors. Though refined surgery and introduction of novel chemotherapeutics have improved outcome, more than 2500 Swedes die from these diseases every year. Novel markers for early diagnosis, prognosis and treatment prediction are therefore needed. This thesis aimed to genetically profile esophageal cancer with correlations to tumor location and prognosis, to explore the contribution of a low-risk allele, and to characterize involvement of signaling pathways in hereditary colorectal cancer. In paper I, 32k array comparative genomic hybridization (aCGH) was used to genomically profile esophageal squamous cell cancer with correlations to prognosis. Copy number alterations affected median 19% of the genome and included frequent alterations of EGFR and CDKN2A. Gain of 7p22.3 predicted nodal metastasis and gain of 1p36.32 and 19p13.3 predicted poor survival. In paper II, aCGH and gene expression profiling were used to identify genetic differences between adenocarcinomas arising at different locations – in the distal esophagus, the gastroesophageal junction and the proximal stomach. Within these genetically complex tumors, extensive similarities were detected in gains/losses and well as gene expression patterns between adenocarcinomas in the distal esophagus and the gastroesophageal junction, whereas gastric cancers showed different profiles. Upregulation of CDK6 and EGFR were found in approximately one quarter of the tumors, which provides molecular support for exploration of these markers as therapeutic targets in gastroesophageal adenocarcinoma. In paper III, the low-risk CHEK2 1100delC allele was characterized in women with metachronous breast cancer and colorectal cancer. The 1100delC allele was identified in 2.5% of the women, compared to 1% in the population. Though alterations in low/moderate risk alleles are increasingly recognized to contribute to hereditary cancer, these findings exclude this CHEK2 variant as a major cause of metachronous breast and colorectal cancer in Swedish women. In papers IV and V, alterations in the PI3K/AKT/mTOR and Wnt signaling pathways were studied in colorectal cancers linked to the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Frequent alterations in these pathways were demonstrated and included mutations of PIK3CA and KRAS and altered immunohistochemical expression of PIK3CA, p-AKT, PTEN, TCF4, ß-catenin and E-cadherin. Therapeutic strategies directed at these pathways are thus likely relevant also in HNPCC-associated cancers.

KW - Esophageal cancer

KW - hereditary cancer

KW - HNPCC

KW - copy number analysis

KW - CGH

KW - gene expression

KW - Wnt

KW - PIK3CA

KW - CHEK2

KW - gastric cancer

KW - colorectal cancer

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16539695

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19731079

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18405350

M3 - Doctoral Thesis (compilation)

SN - 978-91-86443-61-0

T3 - Lund University Faculty of Medicine Doctoral Dissertation Series

PB - Lund University: Faculty of Medicine

ER -

Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer

Sammanfattning

Bibliografisk information

Ämnesklassifikation (UKÄ)

Andra filer och länkar

Fingeravtryck

Aktiviteter

Isinger Ekstrand, A.: Genomic Profiling, Mutations and Deranged Signaling in Esophageal Cancer and Hereditary Colorectal Cancer

Citera det här